In daily pediatric practice, shared decision-making is already happening, often more than is acknowledged,” a pediatrician writes.

The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies ...

The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the ...

European regulators have started a review of Amgen’s drug Tavneos following “emerging information that raises questions ...

Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work ...

According to “Why Should I Trust You?” hosts Tom W. Johnson and Brinda Adhikari, public health’s disengagement from MAHA has ...

A majority of respondents (67%) say Congress did the “wrong thing” by not yet extending the ACA enhanced premium tax credits, though judgement fell largely across party lines. While 89% of Democrats ...

A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...

Three U.S. senators sent a letter to the HHS Office of Inspector General raising questions about TrumpRx — whose structure ...

The proposal would mark a significant change for the secretive PBM industry, which often shields crucial data from its clients.

Glioblastoma is almost always fatal. Altido Bio is trying to commercialize a CAR-T cell therapy that has shown rare promise.

As more consumers order up lab tests and genetic screenings, experts say it could impact insurance, loans, and employment decisions.